1 Result(s)
within
English
Biomedicine
Biomedicine, general
Cancer Research
Medicine/Public Health, general
Oncology
George Kim
-
Article
Open AccessA phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients
The aim of this study was to determine whether checkpoint kinase 1 inihibitor (CHK1), LY2603618, and gemcitabine prolong overall survival (OS) compared to gemcitabine alone in patients with unresectable pancre...
